Woliklin MR 500mg/50mg/325mg Tablet

Introduction

Woliklin MR is a medication that combines three active ingredients: Chlorzoxazone, Diclofenac, and Paracetamol. It is commonly prescribed to alleviate pain and inflammation associated with musculoskeletal conditions.

Uses

Woliklin MR is primarily used to provide relief from pain and inflammation caused by conditions such as muscle spasms, joint pain, sprains, strains, and rheumatoid arthritis. It is often prescribed by healthcare professionals to help manage these conditions and improve the patient’s quality of life.

Dosage and Administration

follow the dosage instructions provided by your healthcare professional. The recommended dose of Woliklin MR may vary depending on the severity of your condition and your individual response to the medication. Typically, the usual adult dosage is one tablet taken orally, three times a day, with or without food. However, consult your healthcare provider for personalized dosage instructions.

Mechanism of Action

Woliklin MR contains three active ingredients, each with its own mechanism of action. Chlorzoxazone is a muscle relaxant that works by blocking the pain sensations between the nerves and the brain. Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) that helps reduce pain and inflammation by inhibiting the production of certain substances in the body. Paracetamol is an analgesic that provides pain relief by acting on certain areas of the brain.

Side Effects

Common side effects may include dizziness, drowsiness, gastrointestinal discomfort (such as stomach pain, nausea, or diarrhea), and skin rash. These side effects are usually mild and transient. However, if you experience any severe or persistent side effects, seek medical attention immediately.

Drug Interactions

Woliklin MR may interact with other medications, including certain blood thinners, diuretics, and certain antidepressants. Inform your healthcare professional about all the medications you are taking, including prescription drugs, over-the-counter medications, and herbal supplements. They can assess the potential interactions and adjust your treatment plan accordingly.

Precautions

Before taking Woliklin MR, inform your healthcare professional about any allergies or sensitivities you may have, as well as any pre-existing medical conditions. This medication is not recommended for individuals with a history of liver or kidney disease, gastrointestinal ulcers, or bleeding disorders. Avoid consuming alcohol while taking Woliklin MR, as it may increase the risk of certain side effects.

Storage

Patient Tips

• Always take Woliklin MR as prescribed by your healthcare professional.
• If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule.
• Do not exceed the recommended dosage without consulting your healthcare provider.
• If you experience any unusual or bothersome symptoms while taking Woliklin MR, contact your healthcare professional.
• maintain a healthy lifestyle, including regular exercise, a balanced diet, and adequate rest, to support the effectiveness of Woliklin MR in managing your condition.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Diclofenac: a non-steroidal anti-inflammatory drug (NSAID) for pain and swelling (NHS UK) [Accessed 0 Jun. 2024] (online) Available at:
• Diclofenac 2.32% gel (Health Professionals SmPC) Available at:
• Chlorzoxazone (Drugs.com) [Accessed 3 Jun. 2024] (online) Available at:
• chlorzoxazone (RX) [Accessed 10 Jun. 2024] (online) Available at:
• Chlorzoxazone (MedlinePlus) [Accessed 22 Jun. 2024] (online) Available at:
• [No authors listed] Chlorzoxazone. 2017 Jan 30. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. [Accessed 29 Jun. 2024] Available at: